Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in structure-based drug design.

G Klebe1

  • 1Institute of Pharmaceutical Chemistry, University of Marburg, Germany. Klebe@mailer.uni-marburg.de

Journal of Molecular Medicine (Berlin, Germany)
|August 23, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of ligand and protein desolvation on ligand binding to the S1 pocket of thrombin.

Journal of molecular biology·2012
Same author

Displacement of disordered water molecules from hydrophobic pocket creates enthalpic signature: binding of phosphonamidate to the S₁'-pocket of thermolysin.

Biochimica et biophysica acta·2010
Same author

Cooperative effects in hydrogen-bonding of protein secondary structure elements: a systematic analysis of crystal data using Secbase.

Proteins·2005
Same author

Strategies for the design of inhibitors of aldose reductase, an enzyme showing pronounced induced-fit adaptations.

Cellular and molecular life sciences : CMLS·2004
Same author

Structural and energetic determinants for enantiopreferences in kinetic resolution of lipases.

Protein engineering·2003
Same author

From structure to recognition principles: mining in crystal data as a prerequisite for drug design.

Ernst Schering Research Foundation workshop·2003
Same journal

Integrative genetic and functional analysis of autosomal dominant hearing loss in 108 multigenerational families.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Zinc-binding protein metallothionein 3 protects vascular smooth muscle cells from ferroptosis via blocking lysosomal degradation of GPX4.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Clinical utility of cerebrospinal fluid interleukin-10 in central nervous system lymphoma: a molecular neuropathology-informed diagnostic meta-analysis.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Molecular regulation of PGC-1α: from protein-protein interactions and post-translational modifications to pharmacological modulation.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Molecular determinants of thromboinflammatory activation in inflammatory bowel disease.

Journal of molecular medicine (Berlin, Germany)·2026
See all related articles

Structure-based design leverages protein structures to create new drugs. This iterative process uses computational methods and experimental validation to improve ligand binding affinity and selectivity for better drug profiles.

Area of Science:

  • Medicinal Chemistry
  • Structural Biology
  • Computational Chemistry

Background:

  • Structure-based design is a novel approach in medicinal chemistry.
  • Understanding molecular recognition in protein-ligand complexes is crucial.
  • Knowledge of protein 3D structures enables direct ligand design.

Purpose of the Study:

  • To describe advances in lead discovery using structure-based design.
  • To highlight the role of computational methods and molecular graphics.
  • To explain the iterative process of ligand design and optimization.

Main Methods:

  • Utilizing known protein crystal structures or homology models.
  • Employing computational screening of compound libraries.
  • Designing novel ligands de novo based on binding pocket features.

Related Experiment Videos

  • Iterative experimental validation and optimization of ligands.

    • Main Results:

    • Demonstrated application of structure-based design in drug development programs.
    • Showcased advances in lead discovery through computer screening and iterative design.
    • Emphasized the importance of understanding selectivity determinants.

    Conclusions:

    • Structure-based design is a powerful iterative approach for drug discovery.
    • Computational tools are essential for hypothesis generation and virtual screening.
    • Optimizing ligand affinity and selectivity is key for pharmacological profiles.